Profile data is unavailable for this security.
About the company
Giant Biogene Holding Co Ltd is an investment holding company primarily engaged in the research, development, manufacture and sale of bioactive material-based beauty and health products. The Company's main products include professional skin treatment products such as functional skincare products and medical dressings, as well as functional foods and others. The Company primarily conducts its businesses in domestic market.
- Revenue in HKD (TTM)6.91bn
- Net income in HKD2.56bn
- Incorporated2021
- Employees2.16k
- LocationGiant Biogene Holding Co LtdShanglin Yuan 7th RoadChang'An District, No. 1855XI'AN ChinaCHN
- Websitehttp://www.xajuzi.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emami Ltd | 3.29bn | 685.49m | 18.66bn | 3.22k | 27.22 | -- | 22.22 | 5.66 | 18.20 | 18.20 | 87.45 | -- | -- | -- | -- | 11,866,520.00 | -- | 22.86 | -- | 30.84 | 69.23 | 65.98 | 20.81 | 20.43 | -- | 54.49 | -- | 50.89 | 6.46 | 7.49 | 11.46 | 21.63 | -22.47 | 14.87 |
| Kose Holdings Corp | 16.90bn | 773.39m | 18.76bn | 8.13k | 22.85 | 1.22 | 12.82 | 1.11 | 264.83 | 264.83 | 5,785.64 | 4,979.35 | 0.8504 | 1.43 | 6.26 | -- | 4.14 | -- | 5.33 | -- | 69.04 | -- | 4.87 | -- | 2.47 | -- | 0.0338 | -- | 2.30 | -- | 101.25 | -- | -- | -- |
| Softcare Ltd | -100.00bn | -100.00bn | 19.37bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.46 | -- | 47.05 | -- | -- | -- |
| Kobayashi Pharmaceutical Co Ltd | 8.48bn | 187.08m | 21.93bn | 3.62k | 111.67 | 1.93 | 34.55 | 2.59 | 49.18 | 49.18 | 2,229.55 | 2,838.34 | 0.6131 | 3.45 | 3.27 | -- | 1.35 | 5.69 | 1.69 | 7.11 | 51.11 | 54.43 | 2.21 | 8.93 | 2.10 | -- | 0.0032 | -- | 0.0858 | 1.95 | -63.68 | -28.23 | 27.56 | -- |
| Lion Corp | 21.60bn | 1.41bn | 24.15bn | 7.65k | 16.92 | 1.45 | 9.05 | 1.12 | 99.68 | 99.68 | 1,525.16 | 1,166.55 | 0.823 | 4.25 | 5.37 | -- | 6.05 | 5.09 | 8.88 | 7.73 | 45.94 | 45.99 | 7.36 | 6.04 | 1.47 | -- | 0.0807 | 34.13 | 2.22 | 3.50 | 30.15 | -1.58 | -6.42 | 5.46 |
| Gillette India Ltd | 2.65bn | 535.50m | 24.39bn | 513.00 | 45.55 | -- | 40.11 | 9.19 | 190.41 | 190.41 | 943.65 | -- | -- | -- | -- | 59,941,520.00 | -- | -- | -- | -- | 63.06 | -- | 20.18 | -- | -- | 67.39 | -- | -- | -- | -- | -- | -- | -- | -- |
| Shanghai Chicmax Cosmetic Co Ltd | 8.37bn | 1.02bn | 25.66bn | 2.46k | 25.09 | 9.34 | 21.36 | 3.07 | 2.57 | 2.57 | 21.02 | 6.90 | 1.99 | 2.83 | 21.36 | 4,010,984.00 | 25.51 | 14.16 | 41.28 | 27.52 | 74.77 | 68.50 | 12.79 | 9.41 | 1.46 | 320.91 | 0.1072 | 36.05 | 62.08 | 18.77 | 69.42 | 65.68 | 8.01 | -- |
| Procter & Gamble Hygiene & Health Care | 3.75bn | 741.77m | 32.73bn | 421.00 | 44.12 | -- | 42.25 | 8.74 | 264.78 | 264.78 | 1,337.25 | -- | -- | -- | -- | 103,105,200.00 | -- | -- | -- | -- | 63.07 | -- | 19.80 | -- | -- | 92.83 | -- | -- | -- | -- | -- | -- | -- | -- |
| Proya Cosmetics Co Ltd | 12.36bn | 1.79bn | 32.87bn | 3.39k | 18.37 | 5.12 | -- | 2.66 | 3.99 | 3.99 | 27.57 | 14.31 | 1.36 | 2.73 | 36.89 | 3,214,578.00 | 20.16 | 17.49 | 26.59 | 23.69 | 72.89 | 68.11 | 14.83 | 13.51 | 2.69 | -- | 0.1355 | 30.17 | 21.04 | 28.11 | 30.00 | 31.63 | 12.85 | 31.64 |
| Hengan International Group Co Ltd | 25.61bn | 2.56bn | 33.97bn | 23.00k | 13.02 | 1.40 | 9.15 | 1.33 | 2.25 | 2.25 | 22.49 | 20.86 | 0.5111 | 4.08 | 9.49 | 1,066,937.00 | 5.11 | 7.09 | 10.00 | 14.09 | 31.80 | 35.87 | 9.99 | 13.32 | 0.9897 | 11.35 | 0.4347 | 66.07 | -4.62 | 0.1563 | -17.93 | -10.07 | 11.56 | -8.42 |
| Giant Biogene Holding Co Ltd | 6.91bn | 2.56bn | 36.41bn | 2.16k | 13.57 | 3.51 | 13.82 | 5.27 | 2.51 | 2.51 | 6.78 | 9.69 | 0.641 | 2.88 | 18.45 | 3,931,337.00 | 23.74 | 26.17 | 29.66 | 47.51 | 81.75 | 83.63 | 37.04 | 43.51 | 4.65 | -- | 0.0008 | 34.32 | 57.17 | 42.08 | 42.06 | 30.15 | 16.52 | -- |
| Unilever Indonesia Tbk PT | 14.85bn | 1.64bn | 40.79bn | 3.30k | 24.79 | 19.52 | 20.53 | 2.75 | 92.79 | 200.92 | 838.70 | 117.82 | 1.77 | 6.73 | 17.95 | 9,682,771,000.00 | 19.62 | 24.75 | 70.67 | 78.09 | 47.76 | 48.72 | 11.07 | 12.29 | 0.5689 | 51.74 | 0.126 | -- | 4.31 | -5.76 | 21.78 | -13.16 | 4.50 | -- |
| Colgate-Palmolive (India) Ltd | 5.09bn | 1.15bn | 50.21bn | 2.20k | 43.83 | -- | 39.40 | 9.86 | 48.80 | 48.80 | 217.04 | -- | -- | -- | -- | 26,852,590.00 | -- | 40.32 | -- | 68.94 | 69.74 | 61.88 | 22.48 | 22.02 | -- | 420.86 | -- | 103.81 | 6.33 | 5.95 | 8.55 | 11.97 | 3.41 | 12.74 |
Data as of Feb 13 2026. Currency figures normalised to Giant Biogene Holding Co Ltd's reporting currency: Hong Kong Dollar HKD
13.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 22 Jan 2025 | 51.29m | 4.79% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 26.24m | 2.45% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 18.68m | 1.74% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 10.60m | 0.99% |
| Rosefinch Fund Management Co., Ltd.as of 30 Jun 2025 | 10.24m | 0.96% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 7.29m | 0.68% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 2025 | 4.92m | 0.46% |
| abrdn Investments Ltd.as of 05 Feb 2026 | 4.82m | 0.45% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2025 | 4.80m | 0.45% |
| Royal London Asset Management Ltd.as of 31 Jan 2026 | 4.43m | 0.41% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
